The Department of Veterans Affairs is issuing a Presolicitation Notice for an Automated Contrast Delivery System intended for the Phoenix VA Healthcare System. This document serves as a Sources Sought Notice, aimed at gathering information regarding potential suppliers and their capabilities in relation to the requirements set out in NAICS code 339112. The VA seeks input on a standard contrast dye injector system that can meet specific characteristics, including programmability for contrast media administration, adjustable dosing, and the use of sterile components to prevent contamination. The response to this notice is not a solicitation but encourages companies to provide detailed capabilities statements and information regarding their compliance with specifications. Interested parties must submit their responses by February 20, 2025, to the designated contracting officer. This request is part of the government's planning process to inform future procurement decisions and is essential for understanding the market landscape for required medical equipment.
The Department of Veterans Affairs (VA) has issued a Request for Information (RFI) to identify potential sources for an automated contrast delivery system compatible with the VA Medical Center in Phoenix, AZ. This RFI seeks information, not offers, to assess market capabilities related to the NAICS code 339112 (with a size standard of 1,000 employees). The specified system must meet essential characteristics, including programmability for contrast and saline administration, customizable dose adjustments, and the inclusion of single-use sterile components to prevent contamination.
Respondents are invited to provide a capabilities statement, business size classification, and additional feedback on the requirements. The RFI includes 19 specific questions addressing compliance with standards, manufacturing status, lead time for delivery, FDA clearance, and more. Submissions should be sent via email by February 20, 2025. This initiative aims to gather crucial information for future acquisition decisions and ultimately enhance the services offered by the VA to veterans through advanced medical technology.